The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

UNUSUAL BRAIN SYNDROME SEEN WITH DIPHENYLHYDANTOIN AND PENTOBARBITAL

Published Online:https://doi.org/10.1176/ajp.120.3.282-a

An unusually severe acute brain syndrome secondary to diphenylhydantoin and pentobarbital is reported. Evaluation and diagnosis were delayed by the periodic quality of the disturbance seen which misled many to view it primarily as hysterical or schizophrenic in nature. The use of diphenylhydantoin in excess of 300 mg. daily seems ill advised.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.